The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2 , Pages 355-360, February 2008

Nitrative stress in refractory asthma

  • Hisatoshi Sugiura, MD, PhD

      Affiliations

    • Third Department of Internal Medicine, Wakayama Medical University School of Medicine, Wakayama, Japan
  • ,
  • Yuichi Komaki, MD, PhD

      Affiliations

    • Division of Respiratory and Infectious Diseases, Tohoku University Graduate School of Medicine, Miyagi, Sendai, Japan
  • ,
  • Akira Koarai, MD, PhD

      Affiliations

    • Third Department of Internal Medicine, Wakayama Medical University School of Medicine, Wakayama, Japan
  • ,
  • Masakazu Ichinose, MD, PhD

      Affiliations

    • Third Department of Internal Medicine, Wakayama Medical University School of Medicine, Wakayama, Japan
    • Corresponding Author InformationReprint requests: Masakazu Ichinose, MD, PhD, Third Department of Internal Medicine, Wakayama Medical University School of Medicine, 811-1 Kimiidera, Wakayama City, Wakayama 641-0012, Japan.

Received 5 October 2007; received in revised form 10 November 2007; accepted 13 November 2007. published online 03 January 2008.

Background

Most asthma is mild and moderate and can be well controlled by low-dose inhaled steroid with or without bronchodilators. However, 5% to 10% of patients with asthma have more troublesome disease despite using such medication. Recent reports showed that nitrative stress induced tissue remodeling in vitro, which is associated with a component of refractoriness in asthma. However, there is no report that nitrative stress is involved in refractory asthma.

Objective

The aim of this study is to evaluate whether patients with refractory asthma have more nitrative stress.

Methods

Ten healthy subjects, 10 patients with well-controlled asthma, and 8 patients with refractory asthma took part in the current study. Exhaled nitric oxide, xanthine oxidase activity in the supernatant of the sputum, immunostaining for the inducible type of nitric oxide synthase, and 3-nitrotyrosine in induced sputum from the subjects were assessed.

Results

All nitrative markers including exhaled nitric oxide (P < .01), immunopositivities for inducible nitric oxide synthase (P < .01), xanthine oxidase activities (P < .01), and 3-nitrotyrosine (P < .01) in sputum from the refractory asthma group were enhanced compared with the well-controlled group. All these nitrative markers in the sputum had a significant negative correlation with the %FEV1 values (P < .01).

Conclusion

These results suggested that patients with refractory asthma have more nitrative stress in their airways compared with patients with well-controlled asthma.

Key words: Refractory asthma, induced sputum, steroids, nitrotyrosine, reactive oxygen species

Abbreviations used: eNO, Exhaled nitric oxide, HDAC 2, Histone deacetylase 2, ICS, Inhaled corticosteroid, iNOS, Inducible nitric oxide synthase, NO, Nitric oxide, RNS, Reactive nitrogen species, XO, Xanthine oxidase

 

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(07)02220-8

doi:10.1016/j.jaci.2007.11.009

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2 , Pages 355-360, February 2008